Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study

Asim V Farooq; Simona Degli Esposti; Rakesh Popat; Praneetha Thulasi; Sagar Lonial; Ajay K Nooka; Andrzej Jakubowiak; Douglas Sborov; Brian E Zaugg; Ashraf Z Badros; Bennie H Jeng; Natalie S Callander; Joanna Opalinska; January Baron; Trisha Piontek; Julie Byrne; Ira Gupta; Kathryn Colby

doi:10.1007/s40123-020-00289-z

Correction to: Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study

Ophthalmol Ther. 2020 Dec;9(4):913-915. doi: 10.1007/s40123-020-00289-z.

Authors

Asim V Farooq¹, Simona Degli Esposti², Rakesh Popat³, Praneetha Thulasi⁴, Sagar Lonial⁵, Ajay K Nooka⁵, Andrzej Jakubowiak⁶, Douglas Sborov⁷, Brian E Zaugg⁸, Ashraf Z Badros⁹, Bennie H Jeng¹⁰, Natalie S Callander¹¹, Joanna Opalinska¹², January Baron¹², Trisha Piontek¹², Julie Byrne¹², Ira Gupta¹², Kathryn Colby⁶

Affiliations

¹ University of Chicago Medical Center, Chicago, IL, USA. afarooq@bsd.uchicago.edu.
² NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, UCL Institute of Ophthalmology, London, UK.
³ University College London Hospitals, NHS Foundation Trust, London, UK.
⁴ Emory Eye Center, Emory University, Atlanta, GA, USA.
⁵ Emory University, Winship Cancer Institute, Atlanta, GA, USA.
⁶ University of Chicago Medical Center, Chicago, IL, USA.
⁷ Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
⁸ Moran Eye Center, University of Utah, Salt Lake City, UT, USA.
⁹ University of Maryland School of Medicine, Baltimore, MD, USA.
¹⁰ Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD, USA.
¹¹ University of Wisconsin, Carbone Cancer Center, Madison, WI, USA.
¹² GlaxoSmithKline, Upper Providence, PA, USA.

Abstract

The authors of the above mentioned article would like to highlight the following corrections, based upon recent changes to the FDA label and guidance on the use of belamaf.

Publication types

Published Erratum